Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prosopagnosia01:24

Prosopagnosia

1.3K
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CMR Predictors of Liver Cirrhosis by MRI in a National Paediatric Fontan Cohort.

European heart journal. Cardiovascular Imaging·2026
Same author

Impact of coronary artery disease on systolic function in severe aortic stenosis-a multimodality imaging study.

European heart journal. Imaging methods and practice·2026
Same author

Hereditary cancer: Germline testing practices across ERN GENTURIS member countries.

European journal of human genetics : EJHG·2026
Same author

CMR T1 and T2 mapping and extracellular volume quantification in systolic phase produces superior image quality with less motion artifacts and equal mapping values compared to conventional diastolic mapping.

Magma (New York, N.Y.)·2026
Same author

Opportunistic Screening of High-Risk Breast Cancer Variants in Hospital Biobank Setting.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Exploring MPM-FLIM for diagnostics of porokeratosis - a pilot study <i>ex vivo</i>.

Biomedical optics express·2026

Related Experiment Video

Updated: May 1, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

[How to recognize neurofibromatosis?].

Sirkku Peltonen, Minna Pöyhönen, Hannele Koillinen

    Duodecim; Laaketieteellinen Aikakauskirja
    |April 15, 2014
    PubMed
    Summary

    Neurofibromatosis 1 (NF1) is an inherited disorder that increases cancer risk. Early detection and patient education are crucial for managing NF1

    Area of Science:

    • Genetics and Hereditary Diseases
    • Oncology
    • Dermatology

    Context:

    • Neurofibromatosis 1 (NF1) affects approximately 1,500 individuals in Finland.
    • The condition is a hereditary disorder predisposing individuals to various cancers.
    • Cutaneous findings are the most common initial indicators of NF1.

    Purpose:

    • To highlight the systemic nature of Neurofibromatosis 1.
    • To emphasize the importance of recognizing NF1 beyond its cutaneous manifestations.
    • To underscore the need for heightened awareness among healthcare professionals and patients regarding NF1 diagnosis and management.

    Summary:

    • Neurofibromatosis 1 (NF1) is an inherited disorder with significant cancer predisposition.
    • While skin findings are common, they can mask serious internal complications affecting various organ systems.

    More Related Videos

    An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
    03:53

    An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

    Published on: October 10, 2025

    679
    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
    05:44

    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

    Published on: May 17, 2024

    1.2K

    Related Experiment Videos

    Last Updated: May 1, 2026

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    3.1K
    An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
    03:53

    An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

    Published on: October 10, 2025

    679
    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
    05:44

    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

    Published on: May 17, 2024

    1.2K
  • Prompt diagnosis and treatment are essential for managing cancers and bone lesions associated with NF1.

    • Impact:

    • Improving the quality of life for individuals with NF1 by addressing both cosmetic and severe complications.
    • Enhancing early diagnosis and timely intervention for potentially life-threatening conditions linked to NF1.
    • Promoting better understanding and knowledge of NF1 among healthcare providers and affected patients for improved disease management.